TXG

10X Genomics Inc

TXG.US 10xgenomics.com + Research + Basket
CIK 0001770787
Employees 1,178
Phone 925 401 7300
Fiscal year end December
IPO Sep 12, 2019
Address 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
81.55
-2.07 (-2.48%)
USD · NASDAQ
52-week range
12.80
102.81
Trading at 76% of the 52-week range
Market Cap
10.63B
P/E Ratio
0.00
Forward P/E
10,000.00
Book Value
6.34
Div. Yield
N/A
% Institutions
117.64%
% Insiders
1.44%

1 Year

+532.2%

3 Year

+128.1%

10 Year

+54.6%
Description

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Actions

Add an action for TXG.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Serge Saxonov Ph.D. Co-Founder, CEO & Director 1977
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer & Director 1975
Mr. Adam S. Taich CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer 1975
Mr. Jim Goodrich Chief of Global Operations NA
Mr. Michael Schnall-Levin Ph.D. Founding Scientist & CTO NA
Ms. Cassie Corneau Manager of Investor Relations & Strategic Finance NA
Dr. Randy Wu General Counsel and Secretary NA
Ms. Mennah Moustafa Chief Commercial Officer NA
Mr. Jens Durruthy Associate Director of Product Management NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 14, 2026 Serge Saxonov N/A Sale 5.00K $24.56 $122.80K SEC
Mar 24, 2026 Serge Saxonov N/A Sale 5.00K $19.52 $97.60K SEC
Mar 23, 2026 Serge Saxonov N/A Sale 10.00K $19.13 $191.30K SEC
Feb 23, 2026 Adam Taich N/A Sale 8.97K $18.58 $166.63K SEC
Feb 23, 2026 Benjamin J Hindson N/A Sale 7.83K $18.58 $145.41K SEC
Feb 23, 2026 Serge Saxonov N/A Sale 9.63K $18.58 $178.96K SEC
Nov 24, 2025 Adam Taich N/A Sale 11.89K $19.00 $225.87K SEC
Nov 24, 2025 Benjamin J Hindson N/A Sale 8.28K $19.00 $157.38K SEC
Nov 24, 2025 Serge Saxonov N/A Sale 13.26K $19.00 $251.96K SEC
Aug 22, 2025 Adam Taich N/A Sale 22.32K $13.79 $307.72K SEC
Aug 22, 2025 Benjamin J Hindson N/A Sale 7.49K $13.79 $103.23K SEC
Aug 22, 2025 Serge Saxonov N/A Sale 9.35K $13.79 $128.91K SEC
May 22, 2025 Adam Taich N/A Sale 4.04K $8.30 $33.57K SEC
May 22, 2025 Benjamin J Hindson N/A Sale 7.49K $8.30 $62.13K SEC
May 22, 2025 Serge Saxonov N/A Sale 9.34K $8.30 $77.55K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 17.63M Jun 30, 2026 13.53% $0.03 -0.63%
BlackRock Inc 10.80M Jun 30, 2026 8.29% $0.01 7.18%
ARK Investment Management LLC 10.00M Jun 30, 2026 7.68% $2.49 -14.63%
Vanguard Portfolio Management, LLC 6.98M Jun 30, 2026 5.36% $0.01 1.01%
Quantinno Capital Management LP 5.47M Jun 30, 2026 4.20% $0.25 1.07%
Vanguard Capital Management, LLC 5.08M Jun 30, 2026 3.90% $0.00 -3.55%
T. Rowe Price Associates, Inc. 4.54M Jun 30, 2026 3.48% $0.02 2,681.00%
Sumitomo Mitsui Trust Group Inc 4.19M Jun 30, 2026 3.22% $0.09 -17.92%
Amova Asset Management Americas, Inc 4.19M Jun 30, 2026 3.22% $2.07 -17.86%
Morgan Stanley - Brokerage Accounts 3.35M Jun 30, 2026 2.57% $0.01 26.18%
The Goldman Sachs Group Inc 3.15M Jun 30, 2026 2.42% $0.01 -20.72%
Geode Capital Management, LLC 3.08M Jun 30, 2026 2.37% $0.01 6.15%
State Street Corp 2.80M Jun 30, 2026 2.15% $0.00 8.21%
Citadel Advisors Llc 2.78M Jun 30, 2026 2.13% $0.01 273.68%
Dimensional Fund Advisors, Inc. 2.23M Jun 30, 2026 1.71% $0.02 8.93%
AQR Capital Management LLC 2.03M Jun 30, 2026 1.56% $0.03 -20.16%
Jacobs Levy Equity Management, Inc. 2.02M Jun 30, 2026 1.55% $0.28 -11.54%
Point72 Asset Management, L.P. 1.85M Jun 30, 2026 1.42% $0.08 0.00%
Capital World Investors 1.49M Jun 30, 2026 1.15% $0.01 2.80%
T. Rowe Price Investment Management,Inc. 1.27M Jun 30, 2026 0.97% $0.03 -0.97%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 3.82M 2.93% ▲ 8.42% Sep 30, 2026
2 ARK Innovation ETF 3.06M 2.35% ▼ 17.66% Sep 30, 2026
3 iShares Russell 2000 ETF 3.03M 2.33% ▼ 1.14% Sep 30, 2026
4 Vanguard Small Cap Index 2.71M 2.08% ▲ 5.92% Sep 30, 2026
5 T. Rowe Price New Horizons 2.65M 2.03% ▲ 11.66% Sep 30, 2026
6 ARK Genomic Revolution ETF 2.46M 1.89% ▼ 1.72% Sep 30, 2026
7 Fidelity Select Health Care 2.13M 1.64% ▲ 32.18% Aug 31, 2026
8 Fidelity Global Innovators Cl F 2.02M 1.55% ▼ 1.86% Jun 30, 2026
9 Fidelity Select Medical Tech and Devcs 2.00M 1.54% ▲ 0.00% Aug 31, 2026
10 Strategic Advisers Fidelity US TtlStk 1.66M 1.27% ▲ 0.30% Aug 31, 2026

Financial Highlights

▼
Market Cap: $10.63B
EBITDA: $-41.20M
Book Value: $6.34
Earnings/Share: $-0.58
Profit Margin: -12.18%
Operating Margin: -15.20%
ROA (TTM): -5.05%
ROE (TTM): -9.40%
Revenue (TTM): $616.91M
Revenue/Share (TTM): $4.83
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -12.70%

Valuation Metrics

Enterprise Value: $10.42B
Trailing P/E: 0.00
Forward P/E: 10.00K

Shares Statistics

Shares Outstanding: 120.21M
Shares Float: 118.19M
% Insiders: 1.44%
% Institutions: 117.64%
Shares Short: 12.73M
Shares Short (Prior Month): 15.37M
Short Ratio: 3.09
Short % Float: 14.33%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$642.82M
Cost of Goods Sold
adjust
$-198.94M
Gross Profit
subtotal
$443.88M
SG&A
adjust
$-316.13M
R&D
adjust
$-238.63M
Operating Income
subtotal
$-110.89M
Other / Non-Operating Items
adjust
$67.34M
Net Income
subtotal
$-43.54M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TXG.US!